nab-Paclitaxel (nab-P) plus gemcitabine (G) for patients (Pts) with locally advanced pancreatic cancer (LAPC): Interim efficacy and safety results from the Phase 2 LAPACT TrialP. A. Philip, Pascal Hammel, F. Portales et al.|Annals of Oncology|2017Cited by 3